Form 4: ClearPoint Neuro Executive Exercises Stock Options, Disposes of Shares for Tax Obligations

ClearPoint Neuro's Chief Business Officer, Jeremy L. Stigall, exercised stock options and disposed of shares to cover tax obligations on March 6, 2024.

Summary

• On March 6, 2024, Jeremy L. Stigall, Chief Business Officer of ClearPoint Neuro, Inc., engaged in transactions involving the company's common stock.
• Stigall exercised 8,889 restricted stock units, converting them into common stock.
• He then disposed of 3,180 shares of common stock at a price of $6.24 to satisfy tax withholding obligations related to the vesting of the restricted stock units.
• Following these transactions, Stigall directly owns 47,694 shares of ClearPoint Neuro common stock and 35,555 restricted stock units.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of insider transactions. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives regarding their holdings of company stock.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they are related to executive compensation and tax obligations.
• The disclosure provides transparency to shareholders regarding insider activity.

Key Dates